Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions

Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jumeau, Raphael, Ozsahin, Mahmut, Schwitter, Juerg, Elicin, Olgun, Reichlin, Tobias, Roten, Laurent, Andratschke, Nicolaus, Mayinger, Michael, Saguner, Ardan M., Steffel, Jan, Blanck, Oliver, Vozenin, Marie-Catherine, Moeckli, Raphael, Zeverino, Michele, Vallet, Véronique, Herrera-Siklody, Claudia, Pascale, Patrizio, Bourhis, Jean, Pruvot, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329991/
https://www.ncbi.nlm.nih.gov/pubmed/32671101
http://dx.doi.org/10.3389/fcvm.2020.00108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329991/
https://www.ncbi.nlm.nih.gov/pubmed/32671101
http://dx.doi.org/10.3389/fcvm.2020.00108

Ejemplares similares